For the effective degradation of lysosomal sphingolipids with short oligosaccharide head groups, special lipid binding and transfer proteins (the sphingolipid activator proteins) are needed. The sphingolipid activator proteins consist of the GM2 activator protein (GM2AP) and the saposins (Saps) A-D. They all facilitate the interaction of the membrane-bound substrate with the water-soluble enzyme at the water-membrane interface and differ from sphingolipid transfer proteins of the cytosol ( 6 ). The anionic lysosomal phospholipid, BMP, is also known to dramatically enhance (glyco)sphingolipid hydrolysis by lysosomal hydrolases and sphingolipid activator proteins ( 7-9 ).Even at low pH values (pH <5.0), BMP conveys negative surface charge to luminal lysosomal vesicles ( 10,11 ). This favors an electrostatic binding of the positively charged activator proteins and the polycationic hydrolases, and enhances degradation of (glyco)sphingolipids substantially ( 7,9,10,(12)(13)(14)(15)(16).The GM2AP, which has a hydrophobic binding cavity for lipids and a binding site for  -hexosaminidase A (HexA) ( 17-19 ), arranges the interaction of ganglioside GM2 with HexA and facilitates the formation of a Michaelis-Menten complex with access of the catalytic site to the carbohydrate head group ( 20,21 ). The whole working mechanism, Abstract Ganglioside GM2 is the major lysosomal storage compound of Tay-Sachs disease. It also accumulates in Niemann-Pick disease types A and B with primary storage of SM and with cholesterol in type C. Reconstitution of GM2 catabolism with  -hexosaminidase A and GM2 activator protein (GM2AP) at uncharged liposomal surfaces carrying GM2 as substrate generated only a physiologically irrelevant catabolic rate, even at pH 4.2. However, incorporation of anionic phospholipids into the GM2 carrying liposomes stimulated GM2 hydrolysis more than 10-fold, while the incorporation of plasma membrane stabilizing lipids (SM and cholesterol) generated a strong inhibition of GM2 hydrolysis, even in the presence of anionic phospholipids. Mobilization of membrane lipids by GM2AP was also inhibited in the presence of cholesterol or SM, as revealed by surface plasmon resonance studies. These lipids also reduced the interliposomal transfer rate of 2-NBD-GM1 by GM2AP, as observed in assays using Förster resonance energy transfer. Our data raise major concerns about the usage of recombinant His-tagged GM2AP compared with untagged protein. The former binds more strongly to anionic GM2-carrying liposomal surfaces, increases GM2 hydrolysis, and accelerates intermembrane transfer of 2-NBD-GM1, but does not mobilize membrane lipids. Components of eukaryotic plasma membranes reach the intraendolysosomal vesicles by endocytotic membrane fl ow ( 1 ). Those vesicles have been identifi ed as platforms for lipid and membrane degradation ( 2 ). They differ from the limiting endosomal membrane by the absence of a glycocalix, a lower cholesterol content, and the cumulative occurrence of the anionic bis(monoacylglycero)phosphate (BMP) ...